Atchison Kayla, Wu Pauline, Watt Jennifer A, Seitz Dallas, Ismail Zahinoor, Goodarzi Zahra
Department of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Medicine, University of Toronto, Toronto, ON, Canada.
Front Dement. 2024 Jun 13;3:1377191. doi: 10.3389/frdem.2024.1377191. eCollection 2024.
Symptoms of psychosis, characterized by delusions and hallucinations, are commonly experienced by persons living with dementia. A systematic review was completed to identify tools to evaluate symptoms of psychosis compared to a reference standard in persons with dementia. Articles reporting correlation values between psychosis tools were also identified.
The search concepts psychosis, dementia, and diagnostic accuracy were used to search MEDLINE, PsycINFO, and Embase. Included articles meeting the primary objective described a tool to assess symptoms of psychosis, delusions, or hallucinations in persons with dementia, a reference standard form of diagnostic assessment for psychosis, and diagnostic accuracy outcomes for the psychosis tool. Secondary objective articles reported correlation values between two or more psychosis tools in persons with dementia.
One study met the primary objective and described the sensitivity and specificity of the Neuropsychiatric Inventory (NPI) and Columbia University Scale for Psychopathology in Alzheimer's Disease (CUSPAD) in identifying symptoms of psychosis, hallucinations, and delusions. The sensitivity of the NPI and CUSPAD in identifying symptoms of psychosis was 83 and 90%, respectively. Nine studies meeting the secondary objective described eleven unique tools and examined the degree to which tools used to assess psychotic symptoms in persons with dementia were related.
The NPI and CUSPAD were identified in a single study as psychosis tools that have been evaluated against a reference standard of psychosis assessment in persons with dementia. Various tools to assess the burden of psychotic symptoms in persons with dementia exist, but the diagnostic accuracy of existing tools remains understudied. Further research on the comparative utility and diagnostic accuracy is required for all psychosis tools used with persons with dementia.
痴呆症患者常出现以妄想和幻觉为特征的精神病症状。本系统评价旨在确定用于评估痴呆症患者精神病症状的工具,并与参考标准进行比较。同时还确定了报告精神病评估工具之间相关性值的文章。
使用精神病、痴呆症和诊断准确性等检索概念,检索MEDLINE、PsycINFO和Embase数据库。纳入的文章若符合主要目标,则需描述一种用于评估痴呆症患者精神病症状、妄想或幻觉的工具、精神病诊断评估的参考标准形式以及该精神病评估工具的诊断准确性结果。符合次要目标的文章则报告痴呆症患者中两种或更多种精神病评估工具之间的相关性值。
一项研究符合主要目标,描述了神经精神量表(NPI)和阿尔茨海默病精神病理学哥伦比亚大学量表(CUSPAD)在识别精神病症状、幻觉和妄想方面的敏感性和特异性。NPI和CUSPAD识别精神病症状的敏感性分别为83%和90%。九项符合次要目标的研究描述了十一种独特的工具,并研究了用于评估痴呆症患者精神病症状的工具之间的相关程度。
在一项研究中,NPI和CUSPAD被确定为已根据痴呆症患者精神病评估参考标准进行评估的精神病评估工具。存在多种用于评估痴呆症患者精神病症状负担的工具,但现有工具的诊断准确性仍研究不足。对于所有用于痴呆症患者的精神病评估工具,需要进一步研究其比较效用和诊断准确性。